Their results showed that Nrg4 upregulation could enhance the efficiency of ADMSCs in reducing IR and other obesity-related metabolic disorders, mainly by suppressing inflammation, enhancing glucose uptake in AT and muscle, and attenuating hepatic lipogenesis. This evidence concerns the gene NRG4 and obesity due to melanocortin 4 receptor deficiency.